| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| nandrolone decanoate | androgen receptor | small molecule | NA | drugbank , DGIDB | Disease Management[MeSHID:D019468] Kidney Failure[MeSHID:D051437] Osteoporosis Postmenopausal[MeSHID:D015663] Senility[MeSHID:D000375] Anemia[MeSHID:D000740] |
0.22 | approved,illicit | agonist |
| nandrolone decanoate | dopamine receptor | small molecule | NA | drugbank | Disease Management[MeSHID:D019468] Kidney Failure[MeSHID:D051437] Osteoporosis Postmenopausal[MeSHID:D015663] Senility[MeSHID:D000375] Anemia[MeSHID:D000740] |
NA | approved,illicit | modulator |
| nandrolone decanoate | dopamine receptor | small molecule | NA | drugbank | Disease Management[MeSHID:D019468] Kidney Failure[MeSHID:D051437] Osteoporosis Postmenopausal[MeSHID:D015663] Senility[MeSHID:D000375] Anemia[MeSHID:D000740] |
NA | approved,illicit | modulator |
| nandrolone decanoate | dopamine receptor | small molecule | NA | drugbank | Disease Management[MeSHID:D019468] Kidney Failure[MeSHID:D051437] Osteoporosis Postmenopausal[MeSHID:D015663] Senility[MeSHID:D000375] Anemia[MeSHID:D000740] |
NA | approved,illicit | modulator |
| nandrolone decanoate | dopamine receptor | small molecule | NA | drugbank | Disease Management[MeSHID:D019468] Kidney Failure[MeSHID:D051437] Osteoporosis Postmenopausal[MeSHID:D015663] Senility[MeSHID:D000375] Anemia[MeSHID:D000740] |
NA | approved,illicit | modulator |
| nandrolone decanoate | dopamine receptor | small molecule | NA | drugbank | Disease Management[MeSHID:D019468] Kidney Failure[MeSHID:D051437] Osteoporosis Postmenopausal[MeSHID:D015663] Senility[MeSHID:D000375] Anemia[MeSHID:D000740] |
NA | approved,illicit | modulator |
| nandrolone decanoate | proto-oncogene c-fos | small molecule | NA | drugbank | Disease Management[MeSHID:D019468] Kidney Failure[MeSHID:D051437] Osteoporosis Postmenopausal[MeSHID:D015663] Senility[MeSHID:D000375] Anemia[MeSHID:D000740] |
NA | approved,illicit | inducer |
| nandrolone decanoate | 5-hydroxytryptamine receptor 1b | small molecule | NA | drugbank | Disease Management[MeSHID:D019468] Kidney Failure[MeSHID:D051437] Osteoporosis Postmenopausal[MeSHID:D015663] Senility[MeSHID:D000375] Anemia[MeSHID:D000740] |
NA | approved,illicit | modulator |
| nandrolone decanoate | 5-hydroxytryptamine 2 receptor | small molecule | NA | drugbank | Disease Management[MeSHID:D019468] Kidney Failure[MeSHID:D051437] Osteoporosis Postmenopausal[MeSHID:D015663] Senility[MeSHID:D000375] Anemia[MeSHID:D000740] |
NA | approved,illicit | modulator |
| nandrolone decanoate | 5-hydroxytryptamine 2 receptor | small molecule | NA | drugbank | Disease Management[MeSHID:D019468] Kidney Failure[MeSHID:D051437] Osteoporosis Postmenopausal[MeSHID:D015663] Senility[MeSHID:D000375] Anemia[MeSHID:D000740] |
NA | approved,illicit | modulator |
| nandrolone decanoate | 5-hydroxytryptamine 2 receptor | small molecule | NA | drugbank | Disease Management[MeSHID:D019468] Kidney Failure[MeSHID:D051437] Osteoporosis Postmenopausal[MeSHID:D015663] Senility[MeSHID:D000375] Anemia[MeSHID:D000740] |
NA | approved,illicit | modulator |
| nandrolone decanoate | insulin-like growth factor 1 receptor | small molecule | NA | drugbank | Disease Management[MeSHID:D019468] Kidney Failure[MeSHID:D051437] Osteoporosis Postmenopausal[MeSHID:D015663] Senility[MeSHID:D000375] Anemia[MeSHID:D000740] |
NA | approved,illicit | inducer |
| click here to return to the previous page | ||||||||